MoonCay Limited
Extending the value of proven medicines through signature-guided combinations.
We identify medicines approaching loss of exclusivity and engineer improved products through co-crystallisation and solid-form technology, creating differentiated therapies with up to 20 years of new patent life.
Scientific foundation
Advanced science for differentiated combinations
Signature discovery
Transcriptional & functional signatures
We map disease and drug response networks to identify rational combination opportunities and patient selection strategies.
Molecular design
Co-crystallisation & solid-form science
Our expertise in crystal engineering and solid-state chemistry creates improved products with differentiated properties.
Data-driven insight
Genomics-guided development
We integrate multi-omics and functional data to de-risk development and support robust IP positioning.
01
Signature-guided combinations
We use transcriptional and functional signatures to rationally design combination regimens that improve on existing standards of care.
02
Loss-of-exclusivity opportunities
We target established medicines coming off patent, where clinical utility is proven but innovation has stalled.
03
Co-crystallisation & solid-form technology
Our formulation expertise creates improved products, new salts, co-crystals and solid forms, with extended IP life and better performance.
Partnerships
Interested in partnering or learning more?
We are building a pipeline of improved, IP-protected combination products.